Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms

Autor: Gretchen N. de Graav, MD, PhD, Marieke van der Zwan, MD, Carla C. Baan, MD, PhD, Joop A.M.J.L. Janssen, MD, PhD, Dennis A. Hesselink, MD, PhD

Publikováno v: Transplantation Direct, Vol 4, Iss 3, p e350 (2018)

Abstract. The introduction of immunosuppressant belatacept, an inhibitor of the CD28-80/86 pathway, has improved 1-year outcomes in kidney transplant recipients with preexistent diabetes mellitus and has also reduced the risk of posttransplant diabet

Externí odkaz: https://doaj.org/article/e2551bf72be542f1bf412c0370c03437

Study partner-and-self-reported difficulties in cognitively complex everyday activities in participants without objective cognitive impairment

Autor: Verrijp, Merike, Dubbelman, MA, Nijhuis, E.W.P., Visser, LNC, Zwan, MD, Jutten, RJ, van Hout, HPJ, van der Flier, WM, Scheltens, P, Sikkes, SAM

Publikováno v: Verrijp, M, Dubbelman, MA, Nijhuis, E W P, Visser, LNC, Zwan, MD, Jutten, RJ, van Hout, HPJ, van der Flier, WM, Scheltens, P & Sikkes, SAM 2020, Study partner-and-self-reported difficulties in cognitively complex everyday activities in participants without objective cognitive impairment. in Alzheimer's and Dementia . Alzheimer's and Dementia . https://doi.org/10.1002/alz.046015
Alzheimer's and Dementia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8c943cb2059b0c609c6eb775eed95b7d
https://research.vumc.nl/en/publications/06b6b76f-82c7-46c6-b1ab-736261eb3304

Digital remote assessment of speech acoustics in cognitively unimpaired adults: feasibility, reliability and associations with amyloid pathology.

Autor: van den Berg RL; Alzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, The Netherlands. r.l.vandenberg@amsterdamumc.nl.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands. r.l.vandenberg@amsterdamumc.nl.; Department of Clinical, Neuro and Developmental Psychology, Faculty of Movement and Behavioral Sciences, VU University, Amsterdam, The Netherlands. r.l.vandenberg@amsterdamumc.nl., de Boer C; Alzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands., Zwan MD; Alzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands., Jutten RJ; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., van Liere M; Alzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands., van de Glind MABJ; Alzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.; Alzheimer Center Groningen, Department of Neurology, Department of Neuropsychology and Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.; Alzheimer Center Erasmus MC and Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Dubbelman MA; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Schlüter LM; Alzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands., van Harten AC; Alzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands., Teunissen CE; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.; Neurochemistry Laboratory and Biobank, Department of Laboratory Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands., van de Giessen E; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Brain Imaging, Amsterdam, The Netherlands., Barkhof F; Amsterdam Neuroscience, Brain Imaging, Amsterdam, The Netherlands.; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, UK., Collij LE; Amsterdam Neuroscience, Brain Imaging, Amsterdam, The Netherlands.; Clinical Memory Research Unit, Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Lund, Sweden., Robin J; Cambridge Cognition, Bottisham, UK., Simpson W; Cambridge Cognition, Bottisham, UK., Harrison JE; Alzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, The Netherlands.; Scottish Brain Sciences, Edinburgh, UK.; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., van der Flier WM; Alzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.; Department of Epidemiology and Biostatistics, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, the Netherlands., Sikkes SAM; Alzheimer Center Amsterdam, Neurology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.; Department of Clinical, Neuro and Developmental Psychology, Faculty of Movement and Behavioral Sciences, VU University, Amsterdam, The Netherlands.

Publikováno v: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Aug 01; Vol. 16 (1), pp. 176. Date of Electronic Publication: 2024 Aug 01.

A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial.

Autor: Deckers K; Department of Psychiatry and Neuropsychology, Alzheimer Centrum Limburg, Mental Health and Neuroscience Research Institute (MHeNs), Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands. kay.deckers@maastrichtuniversity.nl., Zwan MD; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands., Soons LM; Department of Psychiatry and Neuropsychology, Alzheimer Centrum Limburg, Mental Health and Neuroscience Research Institute (MHeNs), Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands., Waterink L; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands., Beers S; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands., van Houdt S; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.; HAN University of Applied Sciences, Nijmegen, The Netherlands., Stiensma B; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Kwant JZ; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Wimmers SCPM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Heutz RAM; Department of Geriatrics, Radboud University Medical Center, Radboudumc Alzheimer Center, Nijmegen, The Netherlands., Claassen JAHR; Department of Geriatrics, Radboud University Medical Center, Radboudumc Alzheimer Center, Nijmegen, The Netherlands.; Radboud University, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.; Department of Cardiovascular Sciences, Leicester University, Leicester, UK., Oosterman JM; Radboud University, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands., de Heus RAA; Department of Geriatrics, Radboud University Medical Center, Radboudumc Alzheimer Center, Nijmegen, The Netherlands.; Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands., van de Rest O; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands., Vermeiren Y; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands., Voshaar RCO; Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Smidt N; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Broersen LM; Danone Research & Innovation, Utrecht, The Netherlands., Sikkes SAM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.; Department of Clinical, Neuro and Developmental Psychology, VU University, Amsterdam, The Netherlands., Aarts E; Radboud University, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands., Köhler S; Department of Psychiatry and Neuropsychology, Alzheimer Centrum Limburg, Mental Health and Neuroscience Research Institute (MHeNs), Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands., van der Flier WM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.; Epidemiology & Data Science, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.

Publikováno v: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Jun 13; Vol. 16 (1), pp. 126. Date of Electronic Publication: 2024 Jun 13.

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.

Autor: Waterink L; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands. l.waterink@amsterdamumc.nl.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, 1081, HV, The Netherlands. l.waterink@amsterdamumc.nl., Masselink LA; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands., van der Lee SJ; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, 1081, HV, The Netherlands.; Genomics of Neurodegenerative Diseases and Aging, Human Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Visser LNC; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, 1081, HV, The Netherlands.; Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 77, Stockholm, Sweden.; Department of Medical Psychology, Amsterdam UMC location AMC, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands.; Amsterdam Public Health research Institute, Quality of Care, Amsterdam, 1105, BP, The Netherlands., Cleutjens S; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands., van der Schaar J; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, 1081, HV, The Netherlands., van Harten AC; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands., Scheltens P; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.; EQT Life Sciences Partners, Amsterdam, 1071, DV, The Netherlands., Sikkes SAM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.; Faculty of Behavioural and Movement Sciences, Department of Clinical, Neuro and Developmental Psychology, Vrije Universiteit, Amsterdam, 1081, HV, The Netherlands., van der Flier WM; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, 1081, HV, The Netherlands.; Department of Epidemiology and Data Science, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, 1081, HZ, The Netherlands., Zwan MD; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Boelelaan 1118, 1081, HZ, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, 1081, HV, The Netherlands.

Publikováno v: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Jan 02; Vol. 16 (1), pp. 1. Date of Electronic Publication: 2024 Jan 02.